interleukin 2 ; Rattus norvegicus






1040 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1280324 Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol Cell Biol 1992 Dec 1
2 1317753 Enhancement of rat hepatic macrophages by treatment with interleukin-2 and streptococcal preparation OK432, with reference to antitumor activity, soluble factor production and Ia expression. Cancer Immunol Immunother 1992 5
3 1330859 [Studies on lymphokine-activated killer (LAK) cell: accumulation in tumor tissue and the therapeutic effects of adoptive immunotherapy]. Hokkaido Igaku Zasshi 1992 Jul 2
4 1343344 The role of natural killer cells and lymphokine activated killer cells in the pathogenesis of hepatic injury in hepatitis A [corrected]. J Clin Lab Immunol 1992 3
5 1366535 Site-directed pegylation of recombinant interleukin-2 at its glycosylation site. Biotechnology (N Y) 1990 Apr 4
6 1367399 Studies of serum-free medium for the generation of lymphokine-activated killer cells. Cytotechnology 1991 May 1
7 1372453 Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL. Transplantation 1992 Mar 1
8 1377926 A comparative study on immunosuppressive effects of cyclosporin A and FK 506 on peripheral blood lymphocytes in dogs. Biotherapy 1992 1
9 1388137 Altered patterns of glycosylation on rat lymphocytes associated with activation. Immunology 1992 Jul 1
10 1392401 In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2. Nat Immun 1992 May-Jun 1
11 1428358 Low dose streptozotocin-induced diabetes in mice: reduced IL-2 production and modulation of streptozotocin-induced hyperglycemia by IL-2. Int J Immunopharmacol 1992 Aug 2
12 1438170 Overexpression and structure--function analysis of a bioengineered IL-2/IL-6 chimeric lymphokine. Protein Eng 1992 Sep 1
13 1444239 Prevention of myelosuppression does not improve the therapeutic efficacy of chemo-immunotherapy. Anticancer Res 1992 Sep-Oct 3
14 1451333 Effect of exogenous cytokines on the inhibition of macrophage-induced, antigen-specific T cell proliferation by poly(I:C). Clin Immunol Immunopathol 1992 Dec 1
15 1457427 Graft cytokine mRNA activity in rat single lung transplants by reverse transcription-polymerase chain reaction: effect of cyclosporine. J Heart Lung Transplant 1992 Nov-Dec 1
16 1457750 Improved efficacy of doxorubicin by simultaneous treatment with interferon-gamma and interleukin-2. In Vivo 1992 Sep-Oct 3
17 1477603 Inhibitory effect by 1,25-dihydroxyvitamin D3 on concanavalin A-stimulated proliferation of rat thymic lymphocytes. Cell Mol Biol (Noisy-le-grand) 1992 Dec 2
18 1478680 Four interleukin-2 surface binding proteins detected in rat spleen cells. Immunology 1992 Nov 9
19 1478705 1,25-Dihydroxyvitamin D3-mediated suppression of T lymphocyte functions and failure of T cell-activating cytokines to restore proliferation. Immunol Lett 1992 Sep 1
20 1483106 Murine lymphocytes exhibit heterogeneity in their proliferative responsiveness to calcium ionophore. Cell Mol Biol (Noisy-le-grand) 1992 Aug-Sep 1
21 1489283 Electron microscopic observation of killer cells induced by mixed culture of lymphocytes with autologous cancer cells and further culture with recombinant interleukin-2. Auris Nasus Larynx 1992 2
22 1495967 Copper deficiency reversibly impairs DNA synthesis in activated T lymphocytes by limiting interleukin 2 activity. Proc Natl Acad Sci U S A 1992 Aug 1 3
23 1512072 IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants. Int J Immunopharmacol 1992 Jul 15
24 1517531 Nicotine enhances interleukin production of rat splenic T lymphocytes. Immunopharmacol Immunotoxicol 1992 1
25 1520312 Effect of 5-fluorouracil on interleukin-2 expression. Biochem Biophys Res Commun 1992 Aug 31 5
26 1524951 Influence of schedule on the therapeutic efficacy of chemoimmunotherapy with doxorubicin and interleukin-2. Biotherapy 1992 1
27 1525954 Deamidation at asparagine-88 in recombinant human interleukin 2. Chem Pharm Bull (Tokyo) 1992 Apr 2
28 1528300 Tumoricidal properties of rat peritoneal macrophages activated with various activators depend on nitrogen oxid synthesis. Neoplasma 1992 1
29 1531763 IL-7 induces proliferation of CD3-/low CD4- CD8- human thymocyte precursors by an IL-2 independent pathway. Int Immunol 1992 Jan 1
30 1531944 Effect of T cell activation on lymphocyte-endothelial cell adherence and the role of VLA-4 in the rat. Cell Immunol 1992 Apr 1
31 1537057 Potentiated lymphokine-activated killer cell activity generated by low-dose interleukin-2 and mismatched double-stranded RNA. Cancer Immunol Immunother 1992 1
32 1541421 Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2. Gut 1992 Feb 1
33 1563015 Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosourea on spontaneous metastases of a non-immunogenic murine tumour. Cancer Immunol Immunother 1992 2
34 1569448 Treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2: a single-center phase II study. J Clin Oncol 1992 May 1
35 1581419 Lymphokine-activated effector cells: modulation of activity by cytokines. Lymphokine Cytokine Res 1992 Apr 3
36 1588036 Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells. J Immunol 1992 Jun 1 1
37 1588792 Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells. Leukemia 1992 Apr 1
38 1612787 Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumors. Int J Cancer 1992 Jul 9 2
39 1614640 Gender differences in immune competence during copper deficiency. Nutr Rev 1992 Apr 1
40 1614979 Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm Res 1992 Mar 2
41 1615018 Stromal cells derived from spleen or bone marrow support the proliferation of rat natural killer cells in long-term culture. Proc Soc Exp Biol Med 1992 Jul 1
42 1623167 A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport 1992 Feb 4
43 1624219 Potentiation of IL-2-induced t-cell proliferation by retinoids. Int J Immunopharmacol 1992 Feb 9
44 1626642 Alterations in brain polyribosomal RNA translation and lymphocyte proliferation in prenatal ethanol-exposed rats. Alcohol Clin Exp Res 1992 Jun 2
45 1634763 Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta. J Immunol 1992 Aug 1 1
46 1639014 Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids. Endocrinology 1992 Aug 1
47 1641114 Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma. Neurosurgery 1992 Jul 1
48 1644897 Pavlovian conditioning of morphine-induced alterations of immune status. J Neuroimmunol 1992 Aug 1
49 1650519 Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases. Agents Actions 1991 Mar 1
50 1657543 Lysis of herpes simplex virus-infected cells by lymphokine-activated killer cells. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1991 Feb 1